Status:

SUSPENDED

Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19

Lead Sponsor:

University of Birmingham

Collaborating Sponsors:

Christian Medical College and Hospital, Ludhiana, India

Ministry of Health, Ghana

Conditions:

Pulmonary Complications in Surgical Patients

COVID

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The aim of this study is to reduce pulmonary complications in adult patients undergoing abdominal or thoracic surgery in COVID-19 exposed hospital environments. A Trial in Low and Middle Income Countr...

Detailed Description

This trial has an adaptive platform design to identify at the earliest opportunity intervention arms which are showing benefit, drop arms which have a clear lack of benefit, and rapidly introduce new ...

Eligibility Criteria

Inclusion

  • Patients aged 18 years and over. (This criteria MUST be made country-specific)
  • Planned to undergo abdominal or thoracic elective or emergency inpatient surgery requiring general anaesthesia.
  • Asymptomatic of COVID-19, including patients with: those not tested, negative test results, positive test but no symptoms (to be monitored post-surgery for symptoms)
  • Informed patient consent.
  • Able to operate a vibrating mesh nebuliser, as assessed by the recruiting physician

Exclusion

  • Procedures under local anaesthesia
  • Known history of adverse reaction/contraindication to trial drug
  • Pregnancy and/or lactating patients (including patients undergoing caesarean section)
  • History of methaemoglobinaemia
  • Patients receiving any type of prescribed nitric oxide-donating agents (e.g. Nitroprusside, Isosorbide dinitrate, Isosorbide mononitrate, Naproxcinod, Molsidomine and Linsidomine)
  • Unable to tolerate use of a nebuliser and/or deemed unlikely to be able to adhere to protocol in view of investigator

Key Trial Info

Start Date :

May 16 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2027

Estimated Enrollment :

6400 Patients enrolled

Trial Details

Trial ID

NCT04386070

Start Date

May 16 2022

End Date

March 1 2027

Last Update

February 20 2025

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

University Of Abuja Teaching Hospital (Spoke)

Gwagwalada, Nigeria, 902101

2

Lagos University Teaching Hospital (Hub)

Lagos, Nigeria

3

Nnamdi Azikiwe University Teaching Hospital (Spoke)

Nnewi, Nigeria, 435101

4

University Teaching Hospital of Butare (CHUB) (Spoke)

Butare, Rwanda

Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19 | DecenTrialz